FDA Panel To Ponder Approval Factors For OTC Infectious Disease Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to hold an advisory panel meeting in mid-August to discuss the potential risks and benefits of clearing or approving over-the-counter infectious disease tests.